Publications Database

Soorya L. , Hollander E. , Kiarashi J. (2008)

Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 753-771

Read Abstract (New Window)

Srivastava R. K. , Agarwal M. , Pundhir A. (2011)

Role of donepezil in autism: its conduciveness in psychopharmacotherapy.

Case Reports in Psychiatry

Read Abstract (New Window) Read Full (New Window)

Stigler K. A. et al. (2010)

Paliperidone for irritability in autistic disorder.

Journal of Child and Adolescent Psychopharmacology

pp. 75-78

Read Extract (New Window)

Stigler K. A. , McDougle C. J. (2008)

Pharmacotherapy of irritability in pervasive developmental disorders.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 739-752

Read Abstract (New Window)

Stigler K. A. (2014)

Psychopharmacologic management of serious behavioral disturbance in ASD.

Child and Adolescent Psychiatric Clinics of North America

January, 23(1), pp. 73-82.

Read Abstract (New Window)

Stigler K. A. et al. (2004)

Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management.

Pediatric Drugs

6(1), pp. 33-44

Read Abstract (New Window)

Sung M. et al. (2014)

What's in the pipeline? Drugs in development for autism spectrum disorder.

Neuropsychiatric Disease and Treatment

(10), pp. 371-381.

Read Abstract (New Window) Read Full (New Window)

Tierney E. et al. (2007)

Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study.

Psychopharmacology (Berl)

March, 191(1), pp. 149-157.

Read Abstract (New Window)

Troost P. et al. (2005)

Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.

Journal of the American Academy of Child and Adolescent Psychiatry

44(11), pp. 1137-1144

Read Abstract (New Window)

Tyrer P. et al. (2008)

Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial.

Lancet

371(9606), pp. 57-63.

Read Abstract (New Window)

Unwin G. L. , Deb S. (2008)

Use of medication for the management of behavior problems among adults with intellectual disabilities: a clinicians' consensus survey.

American Journal of Mental Retardation

113(1), pp. 19-31

Read Abstract (New Window)

Valdovinos M. G. et al. (2002)

Multimodal evaluation of risperidone for destructive behavior: functional analysis, direct observations, rating scales, and psychiatric impressions.

Experimental and Clinical Psychopharmacology

10(3), pp. 268-275

Read Abstract (New Window)

Vercellino F. et al. (2001)

Open-label risperidone treatment of 6 children and adolescents with autism

Canadian Journal of Psychiatry

August, 46(6), pp.559-560.

Vitiello B. et al. (2005)

Assessment of the integrity of study blindness in a pediatric clinical trial of risperidone.

Journal of Clinical Psychopharmacology

25(6), pp. 565-569

Read Abstract (New Window)

Vo L. C. et al. (2016)

No apparent cardiac conduction effects of acute treatment with risperidone in children with autism spectrum disorder.

Perceptual and Motor Skills

December, 26(10), pp. 900-908

Read Abstract (New Window)

Weeden M. , Ehrhardt K. , Poling A. (2009)

Conspicuous by their absence: Studies comparing and combining risperidone and applied behavior analysis to reduce challenging behavior in children with autism.

Research in Autism Spectrum Disorders

pp. 905-912.

Read Abstract (New Window)

Williams S. K. et al. (2006)

Risperidone and adaptive behavior in children with autism.

Journal of the American Academy of Child and Adolescent Psychiatry

45(4), pp. 431-439

Read Abstract (New Window) Read Full (New Window)

Wink L. K. , Erickson C. A. , McDougle C. J. (2010)

Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders.

Current Treatment Options in Neurology

12(6), pp. 529-538.

Read Abstract (New Window)

Zarcone J. R. et al. (2001)

Effects of risperidone on aberrant behavior of persons with developmental disabilities: I: A double-blind crossover studies using multiple measures.

American Journal on Mental Retardation

November, 106(6), pp. 525-538.

Read Abstract (New Window)

Zuddas A. et al. (2000)

Long-term risperidone for pervasive developmental disorder: efficacy, tolerability, and discontinuation.

Journal of Child and Adolescent Psychopharmacology

10(2), pp. 79-90

Read Abstract (New Window)